Evaluation of steady-state pharmacokinetic interactions between ritonavir-boosted BILR 355, a non-nucleoside reverse transcriptase inhibitor, and lamivudine/zidovudine in healthy subjects
Year: 2010
Type: article
Study design: Clinical Trial
Authors: F. Huang, L. Allen, D. B. Huang, F. Moy, R. Vinisko, T. Nguyen, L. Rowland, T. R. MacGregor, M. A. Castles, P. Robinson
Institution: Boehringer Ingelheim (United States)
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: Boehringer Ingelheim
OpenAlex ID: W1590925586
